The Gross Margin of Arcutis Biotherapeutics Inc (ARQT) is 90.27%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 90.27% |
2023-12-31 | 91.63% |
2022-12-31 | 79.40% |